Genomics may very well be the following large factor within the biotechnology area. Equally, the In
Genomics may very well be the following large factor within the biotechnology area. Equally, the International X Genomics & Biotechnology ETF (GNOM) may very well be the following large fund, and is already up 10% to begin the brand new 12 months.
GNOM seeks to offer funding outcomes that correspond typically to the worth and yield efficiency of the Solactive Genomics Index that’s designed to offer publicity to exchange-listed firms which might be positioned to learn from additional advances within the discipline of genomic science and biotechnology, in addition to functions thereof (collectively, “Genomics & Biotechnology Firms”), as outlined by Solactive AG, the supplier of the underlying index.
GNOM provides traders:
- Excessive Development Potential: GNOM permits traders to entry excessive development potential by means of firms which might be positioned to learn from additional advances within the discipline of genomic science.
- Focused Publicity: GNOM offers entry to rising areas inside the Well being Care Sector on the intersection of science and know-how.
- ETF Effectivity: In a single commerce, GNOM delivers entry to dozens of firms with publicity to the genomics theme.
The fund has been a stellar performer the previous 12 months, rising over 60%:
Capitalizing on Genomics’ Enormous Potential
The genomics area will solely proceed to develop as biotechnological advances hold fueling the trade. An Investing.com article spoke to the trade’s potential finest:
“Whereas initially, it may be arduous to completely wrap your head across the idea of genomics, it’s straightforward to know that firms within the trade have big potential. A genome is an organism’s full set of DNA, together with all of its genes. Due to this fact, genomics is a discipline of biology that entails finding out all of an individual’s genes and attempting to find out their interactions and affect on an individual’s well being. The functions of genomics are really fascinating, as scientists can doubtlessly use the knowledge from genomics to assist people stay longer and more healthy lives.”
For extra information and data, go to the Thematic Investing Channel.
Learn extra on ETFtrends.com.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.